| Literature DB >> 27775869 |
Ewelina Mnich1, Ruben Vanholme2,3, Paula Oyarce2,3, Sarah Liu4, Fachuang Lu4, Geert Goeminne3, Bodil Jørgensen5, Mohammed S Motawie1, Wout Boerjan2,3, John Ralph4, Peter Ulvskov5, Birger L Møller1,6, Nanna Bjarnholt1, Jesper Harholt5,6.
Abstract
Lignin is a major polymer in the secondary plant cell wall and composed of hydrophobic interlinked hydroxyphenylpropanoid units. The presence of lignin hampers conversion of plant biomass into biofuels; plants with modified lignin are therefore being investigated for increased digestibility. The bacterium Sphingomonas paucimobilis produces lignin-degrading enzymes including LigD, LigF and LigG involved in cleaving the most abundant lignin interunit linkage, the β-aryl ether bond. In this study, we expressed the LigD, LigF and LigG (LigDFG) genes in Arabidopsis thaliana to introduce postlignification modifications into the lignin structure. The three enzymes were targeted to the secretory pathway. Phenolic metabolite profiling and 2D HSQC NMR of the transgenic lines showed an increase in oxidized guaiacyl and syringyl units without concomitant increase in oxidized β-aryl ether units, showing lignin bond cleavage. Saccharification yield increased significantly in transgenic lines expressing LigDFG, showing the applicability of our approach. Additional new information on substrate specificity of the LigDFG enzymes is also provided.Entities:
Keywords: zzm321990Sphingomonas paucimobiliszzm321990; Ligβ-aryl ether; bacteria; biofuel; lignin modification; saccharification yield
Mesh:
Substances:
Year: 2016 PMID: 27775869 PMCID: PMC5399005 DOI: 10.1111/pbi.12655
Source DB: PubMed Journal: Plant Biotechnol J ISSN: 1467-7644 Impact factor: 9.803
Figure 1Pathway for degradation of β–O–4‐linked units by Lig enzymes from S. paucimobilis exemplified with the model compound GGE (Masai et al., 2003). GGE, guaiacylglycerol‐β‐guaiacyl ether; MPHPV, α‐(2‐methoxyphenoxy)‐β‐hydroxypropiovanillone; GS‐HPV, α‐glutathionyl‐β‐hydroxypropiovanillone; HPV, β‐hydroxypropiovanillone; GSH, glutathione.
Figure 2Detection of LigDFG catalysed products and intermediates formed in transgenic Arabidopsis plants expressing Lig. The chromatogram in the upper panel shows the retention times of the reference compounds. In the panels below, the metabolism of guaiacylglycerol‐β‐guaiacyl ether following incubation with leaf protein extracts from a transgenic line and wild‐type plants is shown. Black line: Extracted ion chromatogram (EIC) for m/z 319 recorded to detect formation of α‐(2‐methoxyphenoxy)‐β‐hydroxypropio‐vanillone. Pink line: EIC for m/z 502 recorded to detect formation of GS‐HPV. Green line: EIC m/z 197 recorded to detect formation of HPV. LigDFG, enzymes LigD, LigF and LigG.
Figure 3Detection of LigD protein in Lig transgenic lines (third‐generation T3) as monitored by Western blotting with anti‐LigD antibody. No bands corresponding to unsuccessful 2A proteolytic cleavage, between LigD and LigF could be detected, as only the shown 31.9 kDa band could be detected with anti‐LigD antibody. The figure is a composite of several blots.
Figure 4Aromatic region of partial 2D HSQC NMR spectra obtained by analysis of three biological replicates of the Lig lines and wild type. A single representative spectrum from each line is shown. The content of particular units is the average of the three replicates. See Table S3 for details.
Figure 5Aliphatic region of partial 2D HSQC NMR spectra obtained by analysis of three biological replicates of the Lig lines and wild type. A single representative spectrum from each line is shown. The content of particular units is the average of the three replicates. See Table S3 for details.
Phenolic compounds which show significant differences between their abundance in LigDFG transgenic Arabidopsis plants and wild type
| nr |
| RT (min) | Identity | WT |
|
|
| Ratio of |
|---|---|---|---|---|---|---|---|---|
| Compounds with increased abundance in amyDFG10 | ||||||||
| HPV‐like compounds | ||||||||
| 1 | 357.12 | 4.50 | HPV + hexose | 1569 | 8751 | 1502 | 2062 | 5.58 |
| 2 | 387.13 | 5.01 | HPS + hexose | 240 | 1944 | 187 | 196 | 8.10 |
| 3 | 399.16 | 6.45 | HPV + hexose + acetate | 2568 | 6277 | 2365 | 2000 | 2.44 |
| Dilignols and dilignol hexosides | ||||||||
| 4 | 373.13 | 11.85 | Gox(β‐O‐4)G | 1838 | 10 382 | 2079 | 2127 | 5.65 |
| 5 | 371.11 | 14.26 | Gox(β‐O‐4)G′ | 246 | 2020 | 132 | 405 | 8.21 |
| 6 | 581.19 | 8.42 | Gox(β‐O‐4)G 4‐O‐hexoside (formic acid adduct) | 28 | 2616 | 32 | 19 | 93.43 |
| Neolignan‐like compounds | ||||||||
| 7 | 549.16 | 8.68 | Gox(β‐O‐4)FA + hexose | 1126 | 8516 | 562 | 982 | 7.56 |
| 8 | 549.16 | 9.19 | Gox(β‐O‐4)FA + hexose | 5 | 1634 | 4 | 4 | 326.80 |
| 9 | 549.15 | 9.73 | Gox(β‐O‐4)FA + hexose | 470 | 4759 | 313 | 375 | 10.13 |
| 10 | 503.12 | 12.21 | Gox(β‐O‐4)FA + malate | 1218 | 11 972 | 1039 | 1351 | 9.83 |
| 11 | 503.12 | 12.85 | Gox(β‐O‐4)FA + malate | 639 | 6681 | 559 | 636 | 10.46 |
| 12 | 665.17 | 9.06 | Gox(β‐O‐4)FA + malate + hexose | 6 | 1358 | 7 | 0 | 226.33 |
| 13 | 665.17 | 9.21 | Gox(β‐O‐4)FA + malate + hexose | 354 | 6307 | 185 | 384 | 17.82 |
| 14 | 773.23 | 14.02 | Gox(β‐O‐4)FA + hexose + sinapic acid | 1897 | 21 354 | 2273 | 2520 | 11.26 |
| 15 | 773.23 | 15.36 | Gox(β‐O‐4)FA + hexose + sinapic acid | 43 | 5128 | 123 | 79 | 119.26 |
| 16 | 935.29 | 11.14 | Gox(β‐O‐4)FA + hexose + hexose + sinapic acid | 94 | 5794 | 114 | 244 | 61.64 |
| 17 | 935.29 | 11.24 | Gox(β‐O‐4)FA + hexose + hexose + SA | 63 | 4159 | 11 | 173 | 66.02 |
| 18 | 935.29 | 11.71 | Gox(β‐O‐4)FA + hexose + hexose + SA | 17 | 1982 | 0 | 75 | 116.59 |
| 19 | 516.15 | 10.13 | Gox(β‐O‐4)FA + glutamic acid | 17 | 1459 | 40 | 18 | 85.82 |
| 20 | 417.12 | 12.29 | Gox(β‐O‐4)SA + malate (‐malate) | 419 | 1620 | 320 | 382 | 3.87 |
| 21 | 417.12 | 13.22 | Gox(β‐O‐4)SA + malate (‐malate) | 218 | 1367 | 193 | 181 | 6.27 |
| Compounds with unknown identity | ||||||||
| 22 | 225.04 | 3.47 | Unknown | 393 | 1010 | 333 | 417 | 2.57 |
| 23 | 385.12 | 12.17 | Unknown | 49 607 | 86 594 | 43 207 | 55 871 | 1.75 |
| 24 | 387.15 | 8.74 | Unknown | 2275 | 6362 | 2198 | 2226 | 2.80 |
| Compounds with decreased abundance in amyDFG10 | ||||||||
| Compounds with unknown identity | ||||||||
| 25 | 419.14 | 8.57 | Unknown | 1583 | 394 | 1319 | 1264 | 0.25 |
| 26 | 389.13 | 8.88 | Unknown | 4931 | 1970 | 3762 | 3823 | 0.40 |
All significant differences in abundance were observed between the amyDFG10 line and wild type. The ratio represents the fold‐change in abundance between the listed transgenic line as compared to wild type. s.d., standard deviation; HPV, hydroxypropiovanillone; HPS, hydroxypropiosyringone; G, guaiacyl unit; Gox, α‐keto‐oxidized guaiacyl unit. The chemical structures of compounds 1–21 are shown in Figure 6.
Figure 6Structures of phenolic compounds which show significant differences between their abundance in Lig transgenic Arabidopsis plants and wild type. Structural identifications of the compounds were essentially based on MS/MS fragmentation data. The structural elucidation of compounds 1–3 is reported in SM, whereas structural characterization of compounds 4–21 has previously been reported (Tsuji et al., 2015).
Figure 7Analysis of saccharification yield in Lig transgenic Arabidopsis plants. Two‐way ANOVA showed statistically significant increases in glucose release from amy (P < 0.02), amy (P < 0.02) and ppi (P < 0.001), with no interaction between genotype and growth cohort (two cohorts, n = 8 in each cohort).
Figure 8Cleavage of a β–O–4‐bond in lignin by the LigDFG enzymes depicting their theoretical contribution to the observed increase in Gox units as revealed by the 2D HSQC NMR spectra.